These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 25130966)
1. [A meta-analysis of Association between MGMT gene promoter methylation and non-small cell lung cancer]. Fang N; Gu J; Wei H; You J; Zhou Q Zhongguo Fei Ai Za Zhi; 2014 Aug; 17(8):601-5. PubMed ID: 25130966 [TBL] [Abstract][Full Text] [Related]
2. MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis. Chen B; Ying X; Bao L Thorac Cancer; 2021 Dec; 12(23):3194-3200. PubMed ID: 34651448 [TBL] [Abstract][Full Text] [Related]
3. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status. Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569 [TBL] [Abstract][Full Text] [Related]
4. Determination of O⁶-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer. Ekim M; Caner V; Büyükpınarbaşılı N; Tepeli E; Elmas L; Bağcı G Genet Test Mol Biomarkers; 2011 May; 15(5):357-60. PubMed ID: 21288129 [TBL] [Abstract][Full Text] [Related]
5. A systematic review and meta-analysis: Association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma. Chen L; Wang Y; Liu F; Xu L; Peng F; Zhao N; Fu B; Zhu Z; Shi Y; Liu J; Wu R; Wang C; Yao S; Li Y Sci Rep; 2018 Jan; 8(1):1439. PubMed ID: 29362385 [TBL] [Abstract][Full Text] [Related]
6. Methylation status of O6-methylguanine-DNA-methyl transferase promoter region in non-small-cell lung cancer patients with brain metastasis. Hashimoto K; Narita Y; Matsushita Y; Miyakita Y; Ono M; Kayama T; Shibui S Clin Transl Oncol; 2012 Jan; 14(1):31-5. PubMed ID: 22262716 [TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma. Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480 [TBL] [Abstract][Full Text] [Related]
8. Prognosis value of MGMT promoter methylation for patients with lung cancer: a meta-analysis. Chen C; Hua H; Han C; Cheng Y; Cheng Y; Wang Z; Bao J Int J Clin Exp Pathol; 2015; 8(9):11560-4. PubMed ID: 26617891 [TBL] [Abstract][Full Text] [Related]
9. Association of MGMT promoter methylation with tumorigenesis features in patients with ovarian cancer: A systematic meta-analysis. Qiao B; Zhang Z; Li Y Mol Genet Genomic Med; 2018 Jan; 6(1):69-76. PubMed ID: 29195029 [TBL] [Abstract][Full Text] [Related]
10. [Meta-analysis of the Association between RASSF1A Gene Promoter Methylation and Non-small Cell Lung Cancer]. Wei H; Fang N; Guo L; Wu Z; Zhou Q Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):443-50. PubMed ID: 26182870 [TBL] [Abstract][Full Text] [Related]
11. The Association Between MGMT Promoter Methylation and Patients with Gastric Cancer: A Meta-Analysis. Yuan X; Xu J; Fang W; Zhao Z; Wang F; Tong Z Genet Test Mol Biomarkers; 2017 Apr; 21(4):213-221. PubMed ID: 28384044 [TBL] [Abstract][Full Text] [Related]
12. Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis. Gu J; Wen Y; Zhu S; Hua F; Zhao H; Xu H; You J; Sun L; Wang W; Chen J; Zhou Q PLoS One; 2013; 8(4):e60107. PubMed ID: 23577085 [TBL] [Abstract][Full Text] [Related]
13. Gene promoter methylation and cancer: An umbrella review. Bouras E; Karakioulaki M; Bougioukas KI; Aivaliotis M; Tzimagiorgis G; Chourdakis M Gene; 2019 Aug; 710():333-340. PubMed ID: 31202904 [TBL] [Abstract][Full Text] [Related]
14. Methylation analysis of APC, AXIN2, DACT1, RASSF1A and MGMT gene promoters in non-small cell lung cancer. Paschidis K; Zougros A; Chatziandreou I; Tsikalakis S; Korkolopoulou P; Kavantzas N; Saetta AA Pathol Res Pract; 2022 Jun; 234():153899. PubMed ID: 35489124 [TBL] [Abstract][Full Text] [Related]
15. [Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells]. Fang HL; Yu ZC; Zhu HB; Jin YT Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):658-63. PubMed ID: 23159077 [TBL] [Abstract][Full Text] [Related]
16. Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis. Gu C; Lu J; Cui T; Lu C; Shi H; Xu W; Yuan X; Yang X; Huang Y; Lu M PLoS One; 2013; 8(9):e72633. PubMed ID: 24086261 [TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of the relationship between RARβ gene promoter methylation and non-small cell lung cancer. Hua F; Fang N; Li X; Zhu S; Zhang W; Gu J PLoS One; 2014; 9(5):e96163. PubMed ID: 24796328 [TBL] [Abstract][Full Text] [Related]
18. Abnormal MGMT promoter methylation may contribute to the risk of esophageal cancer: a meta-analysis of cohort studies. Zhao JJ; Li HY; Wang D; Yao H; Sun DW Tumour Biol; 2014 Oct; 35(10):10085-93. PubMed ID: 25015189 [TBL] [Abstract][Full Text] [Related]
19. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis. Huang J; Luo JY; Tan HZ PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102 [TBL] [Abstract][Full Text] [Related]
20. MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinoma. Lei L; Jiang Z; Zhang G; Cheng Q; Lu H World J Surg Oncol; 2018 Jun; 16(1):110. PubMed ID: 29914531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]